DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $32,287,000 | -0.9% | 223,549 | -1.9% | 0.35% | +0.6% |
| Q2 2019 | $32,565,000 | +9.6% | 227,856 | +1.2% | 0.35% | +8.8% |
| Q1 2019 | $29,725,000 | +26.5% | 225,159 | -1.2% | 0.32% | +12.7% |
| Q4 2018 | $23,498,000 | -4.1% | 227,863 | +1.1% | 0.28% | +12.7% |
| Q3 2018 | $24,500,000 | +16.4% | 225,472 | +5.7% | 0.25% | +11.1% |
| Q2 2018 | $21,047,000 | -37.2% | 213,290 | -37.7% | 0.23% | -39.4% |
| Q1 2018 | $33,530,000 | -30.1% | 342,451 | -33.7% | 0.37% | -26.3% |
| Q4 2017 | $47,978,000 | +5.1% | 516,893 | -2.9% | 0.51% | +0.8% |
| Q3 2017 | $45,642,000 | -3.6% | 532,089 | -5.2% | 0.50% | -6.2% |
| Q2 2017 | $47,354,000 | -3.7% | 561,131 | -2.4% | 0.54% | -5.1% |
| Q1 2017 | $49,163,000 | +26.4% | 574,804 | +15.0% | 0.56% | +13.9% |
| Q4 2016 | $38,891,000 | +25.0% | 499,625 | +25.9% | 0.50% | -7.1% |
| Q3 2016 | $31,119,000 | +7564.8% | 396,970 | +9784.7% | 0.53% | +7514.3% |
| Q2 2016 | $406,000 | +28.1% | 4,016 | +20.0% | 0.01% | +16.7% |
| Q1 2016 | $317,000 | – | 3,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |